Introduction {#s1}
============

Delivering high-quality care equitably is an important aspiration of a high-performing health system. Disparities related to socioeconomic status are of particular concern. Several studies have identified sociodemographic disparities in the incidence of disease, prevalence of risk factors, life expectancy[@R1] and disparities after acute healthcare events, a period of increased vulnerability. Among other sociodemographic factors, lower educational attainment is associated with limited access to healthcare, worse socioeconomic status and unhealthy lifestyle behaviours,[@R5] all of which contribute excess risk for poor outcomes.

Given the important role of secondary prevention therapies and behavioural modification in improving outcomes, acute myocardial infarction (AMI) is an important condition to assess for disparities in post-acute care. It is plausible that education and other sociodemographic factors that are not directly related to the severity of an AMI may have an impact on outcomes. Understanding these relationships is particularly important in China, which is experiencing a growing burden of AMI and where levels of educational attainment vary widely.[@R7] Moreover, China is in the midst of a healthcare reform that seeks to provide the population with greater access to high-quality care and essential medications.[@R8] If, despite the reform efforts, persistent disparities by education exist, then China may need to adopt different strategies to achieve greater equity. If present, it would be important to determine if disparities associated with education can be explained by other factors, such as cardiovascular risk profiles, that could potentially identify targets for future interventions to reduce such disparities. The evidence from Western nations is equivocal and is unlikely to generalise to the unique sociocultural and political landscape of China.[@R10]

Accordingly, using data from a large, national, prospective study, we sought to examine the association between educational attainment and clinical outcomes among Chinese patients hospitalised for AMI and to explore potential clinical factors that could potentially drive this association.

Methods {#s2}
=======

Data source and study population {#s2a}
--------------------------------

The design of the China Patient-centred Evaluative Assessment of Cardiac Events-Prospective AMI Study has been published previously.[@R14] In brief, it is a large nationwide prospective study that consecutively recruited patients from 53 hospitals (35 tertiary and 18 secondary hospitals) throughout the 21 provinces in China between 2012 and 2015. Patients were eligible if they were ≥18 years of age, hospitalised for AMI and presented within 24 hours of onset of symptoms. The diagnosis of AMI was consistent with the third universal definition.[@R15] Patients were excluded if they died or were withdrawn from treatment during hospitalisation (n=19), were transferred to another facility (n=13), were lost to follow-up at 1 year after discharge (n=25) or did not have data on education (n=21). In total, 3369 eligible patients were included in our analysis, representing 97.7% of the adults discharged alive following an AMI ([figure 1](#F1){ref-type="fig"}). Enrolled patients completed a baseline interview during hospitalisation and were followed up at 1, 6 and 12 months postdischarge. All participants provided written informed consents at the initial visit.

![Flowchart of the study cohort. AMI, acute myocardial infarction.](heartjnl-2018-313752f01){#F1}

The Chinese government including Ministry of Science and Technology and National Health and Family Planning Commission had no role in the study design, data collection, data analysis and interpretation, or in the preparation of the report. The study was registered at [www.clinicaltrials.gov](www.clinicaltrials.gov) (NCT01624909).

Education status {#s2b}
----------------

We collected information on socioeconomic characteristics with a standardised questionnaire in an in-person interview. Education was self-reported as a five-level categorical variable ranging from illiterate to college/postgraduate. For reporting and analysis, we aggregated education categories into three levels: high (senior high school, college or postgraduate degree), intermediate (junior high school) or low (primary school or below) based on the distribution of education variable. The educational profile in our study was similar to the results of the latest national population sampling survey in China.[@R16]

Patient characteristics {#s2c}
-----------------------

We obtained demographic and clinical characteristics through abstraction of medical charts for the index hospitalisation, supplemented with patient interviews. Age and sex were collected as demographic information. Clinically relevant variables reflecting cardiovascular risk profile were selected based on a review of the literature. These included diabetes, hypertension, hyperlipidaemia, smoking status, family history of coronary heart disease (CHD), systolic blood pressure (SBP) and heart rate at admission, as well as evidence of prior cardiovascular diseases such as AMI, heart failure, angina and stroke. We included time to hospital arrival defined as the time between symptom onset and hospital arrival in hours using the documented timestamp of medical charts. As a marker of clinical severity on presentation, mini-GRACE risk score and left ventricular ejection fraction (LVEF) on initial presentation were also included. The mini-GRACE risk score is a modified and valid version of the GRACE risk score that includes variables for age, SBP at admission, ST-segment deviation on ECG, cardiac arrest at admission, elevated cardiac enzyme levels and heart rate at admission.[@R17] We abstracted data on hospital treatments from medical charts, such as coronary angiography, revascularisation including percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG), thrombolytic therapy, inhospital and discharge medications.

Outcomes {#s2d}
--------

The outcomes of interest in our study were major adverse cardiovascular event (MACE) and death from any cause within 1 year of discharge. MACE was defined as death from any cause, hospitalisations for non-fatal myocardial infarction, non-fatal stroke or heart failure. We ascertained major adverse events with the same approach used in our large international multicentre trials.[@R18] We collected information on clinical events through follow-up interviews, and local clinic staff sought information systematically from relevant hospital records and death certificates. If a patient was unable or unwilling to attend the scheduled interview, information was collected over the telephone through a direct conversation between study physicians and patients or their relatives. All data were centrally adjudicated at the national coordinating centre by trained clinicians.

Statistical analysis {#s2e}
--------------------

We examined differences in demographic and cardiovascular disease characteristics across education categories using Kruskal-Wallis test for trend of continuous variables (ie, age), and Mantel-Haenszel tests for trends of categorical variables (all other variables).

We compared 1-year MACE and mortality across education levels using Kaplan-Meier analysis and log-rank tests. In multivariable models, we evaluated the independent effect of education on 1-year MACE and mortality using survival analysis with frailty proportional hazards models, which explicitly accounted for clustering of patients within hospitals.[@R19] We then evaluated for the effects of education in sequential multivariable models by adding sequential sets of covariates. Specifically, we first used Cox model to assess the relationship of outcomes with education (model 1) and then examined for changes in the association between education and outcomes after adjusting for demographic characteristics including age and sex (model 2). We then added covariates for cardiovascular clinical characteristics in addition to model 2 (model 3), in order to assess for the confounding effect of cardiovascular risk factors on the association between education and outcomes. Candidate variables of clinical characteristics in the model included diabetes, hypertension, hyperlipidaemia, smoking status, SBP at admission, heart rate at admission, AMI, heart failure, angina, stroke, family history of CHD, LVEF, mini-GRACE risk score, time from symptom to hospital arrival, inhospital coronary angiography, inhospital revascularisation and inhospital thrombolytic therapy. The proportional hazards assumption was checked for the full adjustment model. In sensitivity analyses, we assessed for the association between education and outcomes after combining low-education and intermediate-education groups or assessing education as a five-group variable.

In this study, follow-up for mortality and MACE was available for 99.3% of the patients. There were no missing data for the selected variables of age, sex and cardiovascular risk profiles. There was no evidence of a significant interaction between age, sex and education.

All tests of significance were two-tailed, with a level of significance set at an alpha of 0.05. Statistical analyses were performed using SAS (V.9.4).

Results {#s3}
=======

Baseline characteristics {#s3a}
------------------------

Our study sample included 3369 patients. The median age of the population was 61 years (range, 52--69), and 781 (23.2%) were women. 1123 (33.3%) had high, 1092 (32.4%) intermediate and 1154 (34.3%) had low educational attainment. Compared with patients with high educational attainment, those with a low educational attainment were older, more frequently women and more likely to have rural cooperative medical service (p\<0.001). Patients in the low educational attainment group had higher rates of heart failure and stroke, were less likely to smoke, had a lower LVEF at presentation and less frequently presented to the hospital within 6 hours after symptom onset than the middle and high educational attainment groups. In terms of the inhospital process measures, patients with a low educational attainment were less likely to receive coronary angiography and revascularisation and had higher rates of thrombolytic therapy. There were no significant differences of inhospital or discharge medication (eg, dual antiplatelet, statins, angiotensin-converting enzyme inhibitor/angiotensin receptor blocker) between diverse education groups ([table 1](#T1){ref-type="table"}).

###### 

Demographic characteristics and cardiovascular risk profile among patients hospitalised with different education levels

  ------------------------------------------------------------------------------------------------------------------------------------------------
                                                   Total\           Low education\   Intermediate education (n=1092)   High education\   P value
                                                   (n=3369)         (n=1154)                                           (n=1123)          
  ------------------------------------------------ ---------------- ---------------- --------------------------------- ----------------- ---------
  Demographics characteristics                                                                                                           

   Age                                                                                                                                   

    Median age, year (IQR)                         61 (52,69)       66 (60, 74)      59 (50, 66)                       57 (49, 67)       \<0.001

    Age \>65 years (%)                             1298 (38.5)      674 (58.4)       309 (28.3)                        315 (28.0)        \<0.001

   Female (%)                                      781 (23.2)       494 (42.8)       185 (16.9)                        102 (9.1)         \<0.001

  Insurance                                                                                                                              \<0.001

   Urban insurance[\*](#tblfn1){ref-type="fn"}     1960 (58.2)      446 (38.6)       593 (54.3)                        921 (82.0)        

   Rural cooperative medical service               1204 (35.7)      649 (56.2)       424 (38.8)                        131 (11.7)        

   Other insurance                                 205 (6.1)        59 (5.1)         75 (6.9)                          71 (6.3)          

  Cardiovascular risk profiles                                                                                                           

  Pre-existing heart disease (%)                                                                                                         

   AMI                                             267 (7.9)        81 (7.0)         88 (8.1)                          98 (8.7)          0.131

   CABG                                            5 (0.1)          3 (0.3)          2 (0.2)                           0 (0.0)           0.108

   PCI                                             233 (6.9)        58 (5.0)         62 (5.7)                          113 (10.1)        \<0.001

   Angina                                          132 (3.9)        50 (4.3)         45 (4.1)                          37 (3.3)          0.203

   Heart failure                                   230 (6.8)        100 (8.7)        61 (5.6)                          69 (6.1)          0.016

   Stroke                                          556 (16.5)       224 (19.4)       180 (16.5)                        152 (13.5)        \<0.001

  Coronary risk factors                                                                                                                  

   Diabetes mellitus (%)                           782 (23.2)       249 (21.6)       256 (23.4)                        277 (24.7)        0.081

   Hypertension (%)                                1876 (55.7)      657 (56.9)       580 (53.1)                        639 (56.9)        0.975

   Dyslipidaemia (%)                               2584 (76.7)      869 (75.3)       834 (76.4)                        881 (78.5)        0.076

   Current smoker (%)                              1969 (58.4)      545 (47.2)       706 (64.7)                        718 (63.9)        \<0.001

   Family history of CHD                           383 (11.4)       79 (6.8)         140 (12.8)                        164 (14.6)        \<0.001

   Median heart rate at admission (IQR)            74 (65, 84)      73.5 (64, 84)    75 (65, 84)                       74 (66, 83)       0.789

   Median SBP at admission (IQR)                   130 (114, 146)   130 (114, 150)   130 (114, 146)                    128 (114,144)     0.222

   Median mini-GRACE (IQR)                         129 (110, 146)   139 (120, 154)   126 (109, 143)                    125 (106, 141)    \<0.001

  LVEF on initial presentation (%)                                                                                                       0.005

   \<0.4                                           244 (7.2)        90 (7.8)         78 (7.1)                          76 (6.8)          

   ≥0.4                                            2648 (78.6)      862 (74.7)       863 (79.0)                        923 (82.2)        

   LVEF unmeasured                                 477 (14.2)       202 (17.5)       151 (13.8)                        124 (11.0)        

  Time from symptom to hospital arrival ≤6 hours   2404 (71.4)      795 (68.9)       768 (70.3)                        841 (74.9)        0.002

  Inhospital process measures, n (%)                                                                                                     

   Coronary angiography                            2579 (76.6)      766 (66.4)       859 (78.7)                        954 (85.0)        \<0.001

   Revascularisation (PCI or CABG)                 2350 (69.8)      702 (60.8)       774 (70.9)                        874 (77.8)        \<0.001

   Thrombolytic therapy                            332 (9.9)        133 (11.5)       110 (10.1)                        89 (7.9)          0.004

   Dual antiplatelet                               2644 (78.5)      880 (76.3)       869 (79.6)                        895 (79.7)        0.620

   Beta-blocker                                    2742 (81.4)      898 (77.8)       902 (82.6)                        942 (83.9)        \<0.001

   ACEI/ARB                                        2472 (73.4)      832 (72.1)       809 (74.1)                        831 (74.0)        0.303

   Statins                                         3319 (98.5)      1132 (98.1)      1078 (98.7)                       1109 (98.8)       0.191

  Medications at discharge, n (%)                                                                                                        

   Dual antiplatelet                               2301 (68.3)      773 (67.0)       737 (67.5)                        791 (70.4)        0.078

   Beta-blocker                                    1727 (51.3)      545 (47.2)       554 (50.7)                        628 (55.9)        \<0.001

   ACEI/ARB                                        1673 (49.7)      565 (49.0)       538 (49.3)                        570 (50.8)        0.393

   Statins                                         2583 (76.7)      867 (75.1)       839 (76.8)                        877 (78.1)        0.094

  1-year outcomes                                                                                                                        

   1-year death                                    84 (2.5)         44 (3.8)         26 (2.4)                          14 (1.2)          \<0.001

   1-year MACE                                     250 (7.4)        126 (10.9)       75 (6.9)                          49 (4.4)          \<0.001
  ------------------------------------------------------------------------------------------------------------------------------------------------

\*Indicates any type of insurance for urban residents in China.

ACEI, angiotensin-converting enzyme inhibitor; AMI, acute myocardial infarction; ARB, angiotensin-receptor blocker; CABG, coronary artery bypass grafting; CHD, coronary heart disease; LVEF, left ventricular ejection fraction; MACE, major adverse cardiovascular event; PCI, percutaneous coronary intervention; SBP, systolic blood pressure.

Education and 1-year outcomes after AMI {#s3b}
---------------------------------------

Kaplan-Meier survival curves for 1-year MACE and all-cause mortality by education group in subjects with AMI are shown in [figure 2](#F2){ref-type="fig"}. Patients with lower educational attainment had higher MACE rates in the year after hospitalisation for AMI. Within 1 year after discharge, about 10.9% in the lowest education group occurred MACE compared with 4.4% of the highest education group (p\<0.001). The 1-year mortality varied significantly with educational attainment. In particular, 1-year mortality was over threefold higher in patients with the lowest educational attainment compared with those with the highest educational attainment (3.8% vs 1.2%, p\<0.001).

![Unadjusted Kaplan-Meier curve. (A) Unadjusted Kaplan-Meier curve: 1-year all-cause mortality by educational attainment. (B) Unadjusted Kaplan-Meier curve: 1-year MACE by educational attainment. MACE, major adverse cardiovascular events.](heartjnl-2018-313752f02){#F2}

[Table 2](#T2){ref-type="table"} shows the relationship between educational attainment and 1-year adverse outcomes after sequentially adjusting for each set of covariates, and covariates meet the proportional hazards assumption. In survival analysis, lower educational attainment was strongly associated with higher 1-year MACE (HR for low vs high education=2.41, 95% CI 1.72 to 3.37). Even after adjusting for demographic and cardiovascular risk profiles, lower educational attainment was independently associated with a higher risk of MACE at 1 year compared with high educational attainment (risk-adjusted HR, 1.68; 95% CI 1.18 to 2.41).

###### 

Sequential risk adjustments on the association between education and long-term outcomes after AMI

  Risk adjustment category                           Intermediate vs high education   Low vs high education                         
  -------------------------------------------------- -------------------------------- ----------------------- --------------------- ---------
  1-year MACE                                                                                                                       
   No adjustment (model 1)                           1.57 (1.09 to 2.25)              0.015                   2.41 (1.72 to 3.37)   \<0.001
   Demographic factors (model 2)                     1.54 (1.07 to 2.22)              0.019                   1.68 (1.18 to 2.39)   0.004
   Demographic factors+CVD risk profiles (model 3)   1.54 (1.07 to 2.21)              0.021                   1.68 (1.18 to 2.41)   0.004
  1-year mortality                                                                                                                  
   No adjustment (model 1)                           1.92 (1.00 to 3.67)              0.050                   3.09 (1.69 to 5.65)   \<0.001
   Demographic factors (model 2)                     1.78 (0.93 to 3.42)              0.083                   1.70 (0.90 to 3.21)   0.101
   Demographic factors+CVD risk profiles (model 3)   1.71 (0.89 to 3.30)              0.109                   1.41 (0.74 to 2.69)   0.300

Model 1, unadjusted; model 2, adjusted for demographic characteristics including age and sex; model 3, model 2 plus adjustment for cardiovascular clinical characteristics.

For 1-year mortality, patients with low education attainment were more likely to die than those with high educational attainment (HR=3.09, 95% CI 1.69 to 5.65). The addition of demographic factors attenuated the association (HR=1.70; 95% CI 0.90 to 3.21), with little additional attenuation after adding cardiovascular risk factors (HR=1.41; 95% CI 0.74 to 2.69).

Sensitivity analysis {#s3c}
--------------------

In sensitivity analysis, where educational attainment was categorised into two (high vs low and intermediate educational groups) and five classes (illiterate, primary school, junior high school, senior high school and college), education remained an independent predictor of MACE, consistent with the results of our primary analysis ([tables 3 and 4](#T3 T4){ref-type="table"}).

###### 

Categorising education into two groups and sequential risk adjustments on relationship

  Risk adjustment category                           Low vs high education   
  -------------------------------------------------- ----------------------- ---------
  1-year MACE                                                                
   No adjustment (model 1)                           1.99 (1.45 to 2.73)     \<0.001
   Demographic factors (model 2)                     1.61 (1.17 to 2.23)     0.004
   Demographic factors+CVD risk profiles (model 3)   1.61 (1.16 to 2.23)     0.004
  1-year mortality                                                           
   No adjustment (model 1)                           2.52 (1.42 to 4.47)     0.002
   Demographic factors (model 2)                     1.74 (0.96 to 3.14)     0.067
   Demographic factors+CVD risk profiles (model 3)   1.54 (0.85 to 2.81)     0.157

Model 1, unadjusted;

model 2, adjusted for demographic characteristics including age and sex;

model 3, model two plus adjustment for cardiovascular clinical characteristics.

###### 

Categorising education into five groups and sequential risk adjustments on the relationship

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Risk adjustment category                           Illiterate vs college\   Primary vs college\   Junior high vs college\   Senior high vs college\                                                       
                                                     (n=319 vs 462)           (n=836 vs 462)        (n=1092 vs 462)           (n=661 vs 462)                                                                
  -------------------------------------------------- ------------------------ --------------------- ------------------------- ------------------------- --------------------- ------- --------------------- -------
  1-year MACE                                                                                                                                                                                               

   No adjustment (model 1)                           2.81 (1.68 to 4.69)      \<0.001               1.80 (1.13 to 2.88)       0.014                     1.34 (0.84 to 2.15)   0.219   0.76 (0.43 to 1.34)   0.341

   Demographic factors (model 2)                     1.79 (1.04 to 3.07)      0.036                 1.42 (0.88 to 2.28)       0.153                     1.39 (0.87 to 2.22)   0.174   0.82 (0.47 to 1.44)   0.490

   Demographic factors+CVD risk profiles (model 3)   1.85 (1.07 to 3.20)      0.029                 1.41 (0.87 to 2.28)       0.162                     1.39 (0.86 to 2.23)   0.175   0.82 (0.47 to 1.45)   0.503

  1-year mortality                                                                                                                                                                                          

   No adjustment (model 1)                           6.57 (2.49 to 17.37)     \<0.001               2.44 (0.92 to 6.45)       0.072                     2.21 (0.85 to 5.75)   0.104   1.26 (0.42 to 3.75)   0.681

   Demographic factors (model 2)                     3.17 (1.15 to 8.75)      0.026                 1.63 (0.61 to 4.37)       0.330                     2.19 (0.84 to 5.72)   0.110   1.38 (0.46 to 4.11)   0.568

   Demographic factors+CVD risk profiles (model 3)   2.37 (1.13 to 6.83)      0.029                 1.43 (0.53 to 3.87)       0.484                     2.08 (0.79 to 5.49)   0.138   1.36 (0.45 to 4.08)   0.588
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Model 1, unadjusted;

Model 2, adjusted for demographic characteristics including age and sex;

Model 3, model two plus adjustment for cardiovascular clinical characteristics.

Discussion {#s4}
==========

In this first comprehensive report of the association between education and outcomes in a national cohort of patients with AMI in China, we found that patients with low educational attainment had a higher risk of adverse cardiovascular events and all-cause mortality in the 1-year period following their hospitalisation for AMI. Compared with senior high school, college or post-graduate degree, those with primary school education or less had a 2.4-fold higher rate of MACE. In the fully adjusted analysis, patients in the low education group had a 1.7-fold higher risk of MACE in the year after AMI than those in high education group. No single risk factor was strongly associated with the outcomes.

Our study expands on previous literature on education and outcomes in several respects. First, we are not aware of any nationwide cohort studies of Chinese adults with AMI followed for a year. One previous Chinese study included an assessment of education for AMI outcomes and indicated that patients with middle or higher school education had lower inhospital mortality than those with primary school degree. However, the study mainly focused on inhospital mortality as the outcome, assessing educational attainment as one of the predictors for inhospital mortality among patients with AMI.[@R20] Another study explored the association between socioeconomic status and financial burden among Chinese patients with CVD, but it did not provide evidence of patients' outcomes, thus we have no idea about the association between education and outcomes among patients with AMI in China.[@R21] Second, we prospectively identified demographic and CVD risk factors that are relevant to the relationship between education and outcomes and found a clear association between low education and adverse cardiovascular outcomes. Studies from Europe and America have found an inconsistent association between education and adverse cardiovascular outcomes among patients with AMI based on their educational status.[@R4] Some of this inconsistency arises from inconsistent assessment and inclusion of important cardiovascular risk factors such as hypertension, dyslipidaemia, smoking and pre-existing heart diseases in the assessment of these differences.[@R11]

The mechanisms underlying the association between less education and higher risks for 1-year MACE remain unclear. We found that the higher rates of MACE among individuals with low educational attainment were attenuated after adjusting for demographic and comorbidity differences between these groups, with differences in demographic factors including age and sex accounting for a substantial proportion of differences in adverse outcomes between these two groups. Moreover, previous studies on education and health point to an array of social, environmental or genetic predisposition factors as being relevant to health outcomes.[@R4] Although adjustments in our analysis have been made, patients in different education groups may have more variations in baseline lifestyle choices and risk factors control due to different latency, and thus further study to fully capture the impact of these factors that extend beyond AMI would be imperative. Additionally, since these education-based differences in post-AMI outcomes still persisted after risk-adjustment, other factors, such as post-acute care and patient-related responses, may be playing an important role in driving these differences. In this respect, those with higher educational attainment may be more adept at post-discharge self-care and seek for the more optimal standard of care treatment.[@R27] Highly educated patients may also have a better understanding of health knowledge and fewer financial barriers to accessing healthcare, leading to improved use of follow-up health services. Dedicated studies would need to focus on the role of follow-up care, medication adherence and the utilisation of rehabilitation services in understanding education-based differences in cardiovascular outcomes. Future targets for intervention in those with low educational attainment can then focus on improving the most challenging aspects of post-discharge care and more rigorous follow-up for these vulnerable patients. These findings could also stimulate policy and public health discussions to develop practical and sustainable strategies such as initiating closely and aggressive care coordination to provide more convenient health access to those populations and creating specific educational materials appropriate for their literacy. While there was a similar association with mortality, there were few deaths (84 deaths in low/high education groups) and our study was likely underpowered any differences between groups.

Several limitations should be considered in the interpretation of this study. First, this was an observational study, so we cannot assume that relationships are causal; there may be unobserved confounders that explain the relationship between education and outcomes. For example, we had limited information on door-to-balloon time and long-term medication usage, which all may be important in further understanding this association. Moreover, we did not explore other issues such as specifics on revascularisation (eg, non-culprit lesion information) after follow-up, while such information could help with hypotheses for the mechanism of the effect, if causal. Second, although the study was conducted in selected hospitals that represented their respective geographic regions, the results of the study may not be generalised to the whole population in China. However, the overall distribution of education-based groups, as well as outcomes among those with AMI, is consistent with those observed in national data from China.[@R28] Third, education category in our study is different from some western studies that considered college or postgraduate as high educational attainment group. However, China has education patterns that are distinctive from western countries: in China, less than one thirds of population possess senior high school or above diploma, and only 13% of the citizens have achieved college or postgraduate degree according to latest national surveys,[@R16] while 88% of the populations in USA completed at least high school education and more than one thirds have finished college degree at the same period.[@R29] The chance to get senior high school education in China is similar to getting college in USA or western countries, and with this respect, we choose the present categorisation as we did in the paper. Fourth, although we determined the definition of MACE based on the literature review, we included only the most important and relevant cardiovascular events as outcomes. Other events such as atrial fibrillation were not included in our analysis. Finally, education attainment was self-reported. However, it is unlikely that self-reported education is biased in ways that relate to health outcomes; for this reason, patient self-report has been used in all prior studies and in international studies and education status is considered reliable.[@R11]

Conclusion {#s5}
==========

We found that less educated patients hospitalised for AMI have worse outcomes in China; efforts to reduce disparities of care in China must include a focus on identifying and mitigating barriers for this vulnerable patient group.

###### Keymessages 

What is already known on this subject?
--------------------------------------

-   In Western countries, there is an inconsistent association between educational attainment and clinical outcomes in patients following an acute myocardial infarction (AMI), however, data from China are limited.

What might this study add?
--------------------------

-   In China, a country with a diverse population and wide variation in levels of education, we observed that patients in the 1-year period following their hospitalisation for AMI in comparison with patients with a senior high school, college or post-graduate degree, those with a primary school or lower education had a 2.4-fold higher rate of major adverse cardiovascular events, even after adjusting for potential confounders.

How might this impact on clinical practice?
-------------------------------------------

-   Given the substantial burden of cardiovascular disease and a global imperative to adopt strategies to achieve greater equity, these findings highlight the need to mitigate the excess risk experienced by those with limited education.
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